This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Pick Core Laboratories (CLB) Stock?
by Zacks Equity Research
Let's see if Core Laboratories (CLB) stock is a good choice for value-oriented investors right now from multiple angles.
Core Laboratories (CLB) Down 25.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Labs' (CLB) Q4 Earnings Meet, Sales Miss Estimates
by Zacks Equity Research
Core Laboratories (CLB) Q4 results benefit from cost-control initiatives and operational efficiencies.
Core Laboratories (CLB) Matches Q4 Earnings Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 0.00% and 1.08%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Core Laboratories (CLB) Q4 Earnings Expected to Decline
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for January 16th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for January 15th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Oil & Gas Stock Roundup: ExxonMobil's Q4 Update, Core Labs' Dividend Cut & More
by Nilanjan Choudhury
Supermajor ExxonMobil (XOM) issued an update on its upcoming fourth-quarter earnings. Meanwhile, Core Labs (CLB) slashed its dividend by 55% and lowered fourth-quarter guidance.
Core Labs (CLB) Cuts Quarterly Dividend, Revises Q4 Guidance
by Zacks Equity Research
Core Labs (CLB) initiates a preliminary view for the first quarter of 2020 wherein it expects its quarterly revenues within $159-$164 million and earnings per share in the 39-41 cents range.
Why Is Core Laboratories (CLB) Up 3.6% Since Last Earnings Report?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Laboratories (CLB) Q3 Earnings and Sales Beat Estimates
by Zacks Equity Research
Better crude oil market fundamentals are likely to scale up international activities, thereby boosting the prospects of Core Laboratories' (CLB) Reservoir Description unit.
Core Laboratories (CLB) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 4.17% and 0.93%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
SLB & HAL Q3 Earnings Review: International Operations Strong
by Nilanjan Banerjee
Significant exposure to profitable international markets have helped Schlumberger (SLB) and Halliburton (HAL) combat weak North American operations in third-quarter 2019.
What Lies Ahead for Oilfield Service in Q3 Earnings?
by Nilanjan Banerjee
Although weak oil pricing and conservative capital spending by US explorers might have acted as headwinds in Q3, rising rig count in international market may have lent support to oilfield service.
Core Laboratories (CLB) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Core Laboratories (CLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for August 28th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Why Is Core Laboratories (CLB) Down 28.1% Since Last Earnings Report?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Labs (CLB) Q2 Earnings In Line, Sales Miss Estimates
by Zacks Equity Research
Core Labs (CLB) generates FCF of $10.1 million in Q2, marking the 71st consecutive quarter that the company has generated FCF.
Core Laboratories (CLB) Meets Q2 Earnings Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 0.00% and -2.61%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for July 16th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
PUMP or CLB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PUMP vs. CLB: Which Stock Is the Better Value Option?
Here's Why You Should Sell Core Labs (CLB) Stock Right Now
by Zacks Equity Research
Conservative capex by North American energy producers and lackluster international and offshore activities are likely to dent Core Labs' (CLB) performance in the near future.
New Strong Sell Stocks for July 2nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.